GLI & Obesity Meds: Rising Costs & Usage – 2024
Rising Costs and Increased Use of Obesity Medications Spark Healthcare Concerns A significant surge in the prescription and utilization of Glucagon-Like Peptide-1 (GLP-1) receptor agonists and other obesity medications is placing a growing strain on healthcare systems and raising questions about accessibility and affordability. Recent data indicates a dramatic increase in both the financial burden … Read more